[go: up one dir, main page]

ES2063381T3 - Antagonistas de los receptores muscarinicos. - Google Patents

Antagonistas de los receptores muscarinicos.

Info

Publication number
ES2063381T3
ES2063381T3 ES90917100T ES90917100T ES2063381T3 ES 2063381 T3 ES2063381 T3 ES 2063381T3 ES 90917100 T ES90917100 T ES 90917100T ES 90917100 T ES90917100 T ES 90917100T ES 2063381 T3 ES2063381 T3 ES 2063381T3
Authority
ES
Spain
Prior art keywords
independently
antagonists
het
formula
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90917100T
Other languages
English (en)
Inventor
David Alker
Peter Edward Cross
Alexander Roderick Mackenzie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Pfizer Corp SRL
Original Assignee
Pfizer Corp Belgium
Pfizer Corp SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Corp SRL filed Critical Pfizer Corp Belgium
Application granted granted Critical
Publication of ES2063381T3 publication Critical patent/ES2063381T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)

Abstract

SE PRESENTAN ANTAGONISTAS RECEPTORES MUSCARINICOS, PARTICULARMENTE UTILES PARA EL TRATAMIENTO DEL SINDROME DE COLON IRRITABLE, DE LA FORMULA, Y SUS SALES FARMACEUTICAMENTE ACEPTABLES, EN DONDE R ES -CN O -CONH2; Y R1 ES UN GRUPO DE LA FORMULA (A), (B), (C) O HET, DONDE R2 Y R3 SON CADA UNA DE ELLAS INDEPENDIENTEMENTE H, ALQUIL C1-C4, ALCOXIDO C1-C4, -(CH2)QOH, HALO, TRIFLUOROMETIL, -(CH2)QNR4R5, -SO2NH2, O -(CH2)QCONR4R5; R4 Y R5 SON CADA UNA DE ELLAS INDEPENDIENTEMENTE H O ALQUIL C1C4; Q ES 0, 1 O 2; R ES 1, 2 O 3; X Y X1 SON CADA UNA DE ELLAS INDEPENDIETEMENTE O O CH2; M ES 1, 2 O 3; N ES 1, 2 O 3, CON LA CONDICION DE QUE CUANDO EL GRUPO -(CH2)M 3 DEL ANILLO DE PIPERIDINA O DE PIRROLIDINA, N SERA 2 O 3; P SERA 0 O 1; Y "HET" SERA PIRIDINIL, PIRACINIL O TIENIL.
ES90917100T 1990-01-06 1990-11-28 Antagonistas de los receptores muscarinicos. Expired - Lifetime ES2063381T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909000304A GB9000304D0 (en) 1990-01-06 1990-01-06 Muscarinic receptor antagonists

Publications (1)

Publication Number Publication Date
ES2063381T3 true ES2063381T3 (es) 1995-01-01

Family

ID=10668925

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90917100T Expired - Lifetime ES2063381T3 (es) 1990-01-06 1990-11-28 Antagonistas de los receptores muscarinicos.

Country Status (11)

Country Link
EP (1) EP0508988B1 (es)
JP (1) JPH0657693B2 (es)
AT (1) ATE102183T1 (es)
DE (1) DE69007126T2 (es)
DK (1) DK0508988T3 (es)
ES (1) ES2063381T3 (es)
FI (1) FI95026C (es)
GB (1) GB9000304D0 (es)
IE (1) IE63691B1 (es)
PT (1) PT96419B (es)
WO (1) WO1991010647A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI931600A7 (fi) * 1990-10-10 1993-05-17 Schering Corp Diaryylimetyylipiperidiinien tai piperatsiinien pyridiinit ja pyridiin i-N-oksidijohdokset, ja yhdisteet ja menetelmät niiden käyttämiseksi
DK0635012T3 (da) * 1992-03-27 1996-08-19 Schering Corp Bis-aryl-carbinolderivater uden broer, præparater indeholdende disse og fremgangsmåder til anvendelse af disse
ES2103675B1 (es) * 1995-01-10 1998-07-01 Almirall Lab Nuevas piperidinas sustituidas.
IL117149A0 (en) * 1995-02-23 1996-06-18 Schering Corp Muscarinic antagonists
US5889006A (en) * 1995-02-23 1999-03-30 Schering Corporation Muscarinic antagonists
AU6852798A (en) * 1997-04-18 1998-11-13 Takeda Chemical Industries Ltd. Process for producing tricyclic compounds and their intermediates
US7317102B2 (en) * 2003-04-01 2008-01-08 Theravance, Inc. Diarylmethyl and related compounds
EP1644356A1 (en) * 2003-07-11 2006-04-12 Theravance, Inc. Substituted 4-amino-1-benzylpiperidine compounds
PE20050963A1 (es) * 2003-10-14 2006-01-11 Glaxo Group Ltd Compuestos derivados de 8-azoniabiciclo [3.2.1]octanos como antagonistas de receptores de acetilcolina muscarinicos
PE20050489A1 (es) * 2003-11-04 2005-09-02 Glaxo Group Ltd Antagonistas de receptores de acetilcolina muscarinicos
US7250414B2 (en) * 2004-03-11 2007-07-31 Theravance, Inc. Diphenylmethyl compounds useful as muscarinic receptor antagonists
US7071224B2 (en) * 2004-03-11 2006-07-04 Theravance, Inc. Diphenylmethyl compounds useful as muscarinic receptor antagonists

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL76583A (en) * 1984-10-19 1988-08-31 Robins Co Inc A H 1-(aminoalkyl)-alpha'alpha-diaryl pyrrolidinyl,piperidino and homopiperidino acetamides and acetonitriles and pharmaceutical compositions containing them
EP0228893A3 (en) * 1985-12-20 1990-01-03 A.H. ROBINS COMPANY, INCORPORATED (a Delaware corporation) Arylalkyl-heterocyclic amines, n-substituted by aryloxyalkyl group in allergy treatment

Also Published As

Publication number Publication date
DE69007126T2 (de) 1994-06-01
GB9000304D0 (en) 1990-03-07
PT96419B (pt) 1998-06-30
FI95026C (fi) 1995-12-11
DK0508988T3 (da) 1994-05-09
EP0508988B1 (en) 1994-03-02
JPH0657693B2 (ja) 1994-08-03
DE69007126D1 (de) 1994-04-07
FI922343A0 (fi) 1992-05-22
IE910019A1 (en) 1991-07-17
JPH05501554A (ja) 1993-03-25
FI922343A7 (fi) 1992-05-22
EP0508988A1 (en) 1992-10-21
FI95026B (fi) 1995-08-31
WO1991010647A1 (en) 1991-07-25
IE63691B1 (en) 1995-05-31
ATE102183T1 (de) 1994-03-15
PT96419A (pt) 1991-10-15

Similar Documents

Publication Publication Date Title
ES2064771T3 (es) Antagonistas de los receptores muscarinicos.
ES2082013T3 (es) Antagonistas de receptores muscarinicos.
ATE207064T1 (de) Benzodiazepinderivate
ES2063381T3 (es) Antagonistas de los receptores muscarinicos.
ES2060020T3 (es) Derivados de pirrolidina.
AR248013A1 (es) Compuesto de imidazol y composicion biocida que los contiene, excluidos sus usos medicinales y veterinarios, y el procedimiento de preparacion de los compuestos i y sus intermediarios.
AR011229A1 (es) Compuestos derivados de adenosina antagonistas en el receptor ai adenosina, procesos para su preparacion, composiciones farmaceuticas que los contieneny su uso en medicina.
ES2059893T3 (es) Derivados de difenilurea.
DK170188A (da) Carbinolderivater
CO4340623A1 (es) Derivados de indolina, metodo de preparacion y uso
AR247389A1 (es) Derivados de 2,4-diamino-5-ciano-pirimidinas, excluidos sus usos terapeuticos, procedimiento para su preparacion, intermediarios y composiciones que las contienen como antiparasitarios
ES2078671T3 (es) Compuestos de tiazolidina, su preparacion y su utilizacion terapeutica.
DE69413393D1 (de) In 15-stellung substituierte 4-azasteroide
PT86830A (pt) Process for preparing 3-amino-di-hydro-]1"-benzopyrans and benzothiopyrans and benzothiopyrans
ES2104865T3 (es) Nuevos derivados de n-ciclohexilbenzamidas, sus preparaciones y sus aplicaciones terapeuticas.
DK429089A (da) Alkylbenzylaminer
MX9300312A (es) Antagonistas benzopiranicos y relacionado de ltb.
ES2108595B1 (es) Derivados de la 3(2h)-piridacinona y procedimiento para su preparacion.
ES2071479T3 (es) Derivados de indano.
SE8503415D0 (sv) Novel isoindolinyl-alkyl-piperazines
ES2066863T3 (es) Tintes reactivos.
DE69226119D1 (de) Cholecystokininantagoniste
ATE117980T1 (de) Serotonin-antagonisten.
AR246162A1 (es) Composicion antimicrobiana
ES2008109B3 (es) Procedimiento de preparacion de aminoalcoholes y de composiciones farmaceuticas que los contienen.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 508988

Country of ref document: ES